This study is helping to better understand non-Hodgkin lymphoma. Our goal is to use our findings to help improve survival and quality of life following a lymphoma diagnosis. The LEO Cohort recently published a groundbreaking research article highlighting the first 5 years of the LEO cohort. Please see our publication page for additional details

Dr. Christopher Flowers, one of the Primary Investigators of the LEO study and Department Chair of Lymphoma/Myeloma at MD Anderson, on the importance of LEO: